Sensorin gets funds for pH sensing system

Sensorin, a company that develops extremely precise pH meters for use in biopharmaceuticals, brought in an undisclosed amount in second-round equity funding today. The money will go toward further development and beta testing of its new pH sensing product.

The electronic system is comprised of a pH sensor inside a disposable probe, that the Burlingame, Calif.-based company says is self-calibrating without drift, for in-line, operator-independent results. These features make it a good fit for bioprocessing applications, and Sensorin hopes to start manufacturing the system commercially next year. In particular, it can be used to test the pH of drug candidates at various stages to ensure their safety, to test waste-water in disposal industries, and to test products of gas and biofuel production processes.

The company says that the funding came from private individual investors in the biopharmaceuticals industry.

Next Story: Apple beats fourth quarter earnings expectations, Jobs touts "stunning" performance
Previous Story: Roundup: Yahoo, Apple pre-earnings reports, Akamai's new ads, and more